Cramer’s lightning round: CVS Health is a buy

Cramer’s lightning round: CVS Health is a buy


Canoo: “Profits. That would really go a long way [in making the stock a better investment right now].”

Apa Corporation: “I like Apache. I think it’s got a lot of natural gas. [Buy]. I can’t believe that management has stuck it out. Good for them.”

Freeport-McMoRan: “I’m sick of Freeport-McMoRan. That stock is a roller coaster.”

GXO Logistics: “I don’t like [insider selling]. … But you’ve got a stock that’s at its low. I wish that hadn’t happened. I think the business will ultimately win out. I like GXO Logistics, but I don’t like [insider selling].”

CVS Health: “I just saw they’re going to authorize those new shots. …I think that stock is a buy and a buy and a buy.”

Montauk Renewables: “Turns out they’re from Pennsylvania, and it’s a winner. I agree. I like it.”

Cramer's lightning round: CVS Health is a buy

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Stellantis stock off 43% as Jeep maker turns five, executes turnaround
Business

Stellantis stock off 43% as Jeep maker turns five, executes turnaround

Stellantis North America COO and Jeep CEO Antonio Filosa speaks during the Stellantis press conference at the Automobility LA 2024 car show at Los Angeles Convention Center in Los Angeles, California, November 21, 2024. Etienne Laurent | AFP | Getty Images DETROIT — Five years after the transatlantic automaker Stellantis was formed through a merger, […]

Read More
Disney dominated the 2025 box office. Here’s how it could keep the crown in 2026
Business

Disney dominated the 2025 box office. Here’s how it could keep the crown in 2026

Courtesy of Disney Enterprises Inc. Blue aliens, a family of superheroes and a city of talking animals boosted the Walt Disney Company to the top of the domestic box office in 2025. Full-year ticket sales in the United States and Canada rose about 4% from 2024 to $9.05 billion. Disney accounted for the highest share […]

Read More
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch
Business

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company’s new GLP-1 pill […]

Read More